• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质-配体复合物叠层中的保守核心亚结构。

Conserved core substructures in the overlay of protein-ligand complexes.

机构信息

Department of Medicinal Chemistry, University of Minnesota College of Pharmacy, Minneapolis, Minnesota 55455, USA.

出版信息

J Chem Inf Model. 2011 Aug 22;51(8):1931-41. doi: 10.1021/ci100475y. Epub 2011 Jul 22.

DOI:10.1021/ci100475y
PMID:21736376
Abstract

The method of conserved core substructure matching (CSM) for the overlay of protein-ligand complexes is described. The method relies upon distance geometry to align structurally similar substructures without regard to sequence similarity onto substructures from a reference protein empirically selected to include key determinants of binding site location and geometry. The error in ligand position is reduced in reoriented ensembles generated with CSM when compared to other overlay methods. Since CSM can only succeed when the selected core substructure is geometrically conserved, misalignments only rarely occur. The method may be applied to reliably overlay large numbers of protein-ligand complexes in a way that optimizes ligand position at a specific binding site or subsite or to align structures from large and diverse protein families where the conserved binding site is localized to only a small portion of either protein. Core substructures may be complex and must be chosen with care. We have created a database of empirically selected core substructures to demonstrate the utility of CSM alignment of ligand binding sites in important drug targets. A Web-based interface can be used to apply CSM to align large collections of protein-ligand complexes for use in drug design using these substructures or to evaluate the use of alternative core substructures that may then be shared with the larger user community. Examples show the benefit of CSM in the practice of structure-based drug design.

摘要

描述了一种用于蛋白质-配体复合物叠加的保守核心子结构匹配(CSM)方法。该方法依赖距离几何来对齐结构相似的子结构,而不考虑序列相似性,而是将子结构从经验上选择的参考蛋白质上的子结构对齐,该参考蛋白质包括结合位点位置和几何形状的关键决定因素。与其他叠加方法相比,CSM 生成的重新定向集合中的配体位置误差减小。由于 CSM 只能在选择的核心子结构在几何上保守时才成功,因此很少出现错位。该方法可用于可靠地叠加大量蛋白质-配体复合物,以优化特定结合位点或亚位点处的配体位置,或者对齐来自大型和多样化蛋白质家族的结构,其中保守的结合位点仅局限于蛋白质的一小部分。核心子结构可能很复杂,必须谨慎选择。我们创建了一个经验选择的核心子结构数据库,以演示 CSM 在重要药物靶标中配体结合位点对齐的实用性。可以使用基于 Web 的界面将 CSM 应用于对齐大型蛋白质-配体复合物集合,以在使用这些子结构进行药物设计时使用,或者评估替代核心子结构的使用,然后可以与更大的用户社区共享。示例显示了 CSM 在基于结构的药物设计实践中的优势。

相似文献

1
Conserved core substructures in the overlay of protein-ligand complexes.蛋白质-配体复合物叠层中的保守核心亚结构。
J Chem Inf Model. 2011 Aug 22;51(8):1931-41. doi: 10.1021/ci100475y. Epub 2011 Jul 22.
2
Designing a new Diels-Alderase: a combinatorial, semirational approach including dynamic optimization.设计新型 Diels-Alderase:一种组合的、半理性的方法,包括动态优化。
J Chem Inf Model. 2011 Aug 22;51(8):1906-17. doi: 10.1021/ci200177d. Epub 2011 Aug 3.
3
Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.谱定量构效关系(Profile-QSAR):一种新型的元定量构效关系方法,它结合了激酶家族的各项活性,可准确预测亲和力、选择性和细胞活性。
J Chem Inf Model. 2011 Aug 22;51(8):1942-56. doi: 10.1021/ci1005004. Epub 2011 Jul 19.
4
Assay Related Target Similarity (ARTS) - chemogenomics approach for quantitative comparison of biological targets.分析物相关靶标相似度(ARTS)——一种用于定量比较生物靶标的化学生物组学方法。
J Chem Inf Model. 2011 Aug 22;51(8):1897-905. doi: 10.1021/ci200105t. Epub 2011 Jul 29.
5
A data mining method to facilitate SAR transfer.一种促进 SAR 转移的数据挖掘方法。
J Chem Inf Model. 2011 Aug 22;51(8):1857-66. doi: 10.1021/ci200254k. Epub 2011 Aug 8.
6
In silico carborane docking to proteins and potential drug targets.计算机模拟碳硼烷对接蛋白质和潜在药物靶标。
J Chem Inf Model. 2011 Aug 22;51(8):1882-96. doi: 10.1021/ci200216z. Epub 2011 Aug 8.
7
Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery.可成药性口袋和结合位点为中心的化学空间:药物发现的范式转变。
Drug Discov Today. 2010 Aug;15(15-16):656-67. doi: 10.1016/j.drudis.2010.05.015. Epub 2010 Jun 4.
8
Generalized modeling of enzyme-ligand interactions using proteochemometrics and local protein substructures.使用蛋白质化学计量学和局部蛋白质亚结构对酶-配体相互作用进行广义建模。
Proteins. 2006 Nov 15;65(3):568-79. doi: 10.1002/prot.21163.
9
Integrated decision support for assessing chemical liabilities.用于评估化学责任的综合决策支持。
J Chem Inf Model. 2011 Aug 22;51(8):1840-7. doi: 10.1021/ci200242c. Epub 2011 Aug 5.
10
CORES: an automated method for generating three-dimensional models of protein/ligand complexes.CORES:一种生成蛋白质/配体复合物三维模型的自动化方法。
J Med Chem. 2004 Sep 9;47(19):4731-40. doi: 10.1021/jm0499054.

引用本文的文献

1
Fragment-based exploration of binding site flexibility in Mycobacterium tuberculosis BioA.基于片段的结核分枝杆菌BioA中结合位点灵活性探索
J Med Chem. 2015 Jul 9;58(13):5208-17. doi: 10.1021/acs.jmedchem.5b00092. Epub 2015 Jun 24.
2
Anthrax toxin lethal factor domain 3 is highly mobile and responsive to ligand binding.炭疽毒素致死因子结构域3具有高度的流动性且对配体结合有反应。
Acta Crystallogr D Biol Crystallogr. 2014 Nov;70(Pt 11):2813-22. doi: 10.1107/S1399004714018161. Epub 2014 Oct 16.
3
Inhibition of Mycobacterium tuberculosis transaminase BioA by aryl hydrazines and hydrazides.
芳基肼和酰肼对结核分枝杆菌转氨酶BioA的抑制作用。
Chembiochem. 2014 Mar 3;15(4):575-86. doi: 10.1002/cbic.201300748. Epub 2014 Jan 31.
4
Ligand placement based on prior structures: the guided ligand-replacement method.基于先前结构的配体放置:引导配体置换方法。
Acta Crystallogr D Biol Crystallogr. 2014 Jan;70(Pt 1):134-43. doi: 10.1107/S1399004713030071. Epub 2013 Dec 25.
5
The structure of the TOG-like domain of Drosophila melanogaster Mast/Orbit.黑腹果蝇Mast/Orbit的类TOG结构域的结构
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013 Jul;69(Pt 7):723-9. doi: 10.1107/S1744309113015182. Epub 2013 Jun 27.
6
Structural characterization of human histidine triad nucleotide-binding protein 2, a member of the histidine triad superfamily.人组氨酸三聚体核苷酸结合蛋白 2 的结构特征,该蛋白是组氨酸三聚体超家族的成员之一。
FEBS J. 2013 Jul;280(14):3389-98. doi: 10.1111/febs.12330. Epub 2013 Jun 10.